Skip to content

Practice of the Short Wave Diathermy (SWD) Application

A Probe Into Practice of the Short Wave Diathermy (SWD) Application in Private Physiotherapy Clinics: a Survey From Ethical Practice & Safety Perspective.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02379143
Enrollment
49
Registered
2015-03-04
Start date
2013-09-30
Completion date
2014-03-31
Last updated
2015-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electromagnetic Fields

Keywords

SWD, EPA, SAFE PRACTICE

Brief summary

Various national & international bodies like FDA, CSP has laid down the guidelines for the reasonable use of SWD electro therapeutic agent (EPA) ensuring safety & effectiveness. However, it remains uncertain, whether the practicing physiotherapists are aware of the very existence of this guidelines and implementing them in daily practice. Any lack of knowledge about this background can endanger the patient safety leading to serious health hazards. In the present survey, 49 physiotherapy practitioners were interviewed with a self-report measure to investigate their knowledge base, mode of application of SWD (6 items) & the awareness about recommended guidelines (5 items) etc.

Detailed description

Study design: cross sectional survey design with the use of a self-report form to record the participant's views was used. Sampling frame consisted of physiotherapists working in private clinics in sub-urban area of Mumbai, Maharashtra, India. Institutional ethic committee of Terna Physiotherapy College granted permission to conduct this survey. The self-report forms were coded in order to conceal the identity of the therapist. In this survey 49 physiotherapists were interviewed with a self-report form consisting of total 23 item. In the initial section of this survey form a general information was collected regarding years of experience (1 item), Types of condition treated (1 item), No of patients treated (item 1) Duration of onset (item 1) & the type of modality used (item 1). Specific items interrogating therapist's knowledge about the EMF generating modality were designed to retrieve the information about dosage prescription (7 item), acquaintance with recommended guidelines & indications (item 5), years of experience with that particular modality (item1), Any kind of side effects observed (item 1), any action taken for the same (item 2), referring personnel for recommending this modality (item 1), overall therapist's experience with the effectiveness of this modality (item1).

Interventions

OTHERinterview method: self report form

the responses about participants perception, behavior pattern and attitude were recorded on the self report form

Sponsors

TPCT's Terna College of Physiotherapy
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Private physical therapists practitioners

Exclusion criteria

* Who were volunteering to participate

Design outcomes

Primary

MeasureTime frameDescription
SELF REPORT FORMONE DAY. 15 MINUTESThis 23 item form was prepared after the extensive discussion with the panel of experts. In the initial section of this survey form a general information was collected regarding years of experience (1 item), Types of condition treated (1 item), No of patients treated (item 1) Duration of onset (item 1) & the type of modality used (item 1). Specific items interrogating therapist's knowledge about the EMF generating modality were designed to retrieve the information about dosage prescription (7 item), acquaintance with recommended guidelines & indications (item 5), years of experience with that particular modality (item1), Any kind of side effects observed (item 1), any action taken for the same (item 2), referring personnel for recommending this modality (item 1), overall therapist's experience with the effectiveness of this modality (item1).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026